Deutsche Bank raised the firm’s price target on Univar to $40 from $32 and keeps a Buy rating on the shares. While the company’s Q4 EBITDA missed by 9% and Q1 EBITDA guidance was 11% below consensus, 2023 EBITDA guidance was raised 3%, the analyst tells investors in a research note. Amid a challenging December earnings season, Univar is the only company in the chemical universe to raise 2023 guidance, the firm says.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UNVR:
- Univar Solutions Reports 2022 Fourth Quarter and Record Full-Year Financial Results; Issues Guidance for 2023
- Univar sees Q1 adjusted EBITDA $200M-$220M
- Univar reports Q4 adjusted EPS 47c, consensus 54c
- Univar Solutions appointed exclusive distributor of Automate oil-based dyes
- Univar signs new Ibuprofen distribution agreement with SI Group in Brazil